Biomarkers of response to enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study.

Authors :: Jindal, Tanya
Kilari, Deepak
Alhalabi, Omar
Nizam, Amanda
Khaki, Ali Raza
Basu, Arnab
Barata, Pedro C.
Bilen, Mehmet Asim
Shah, Sumit
Zakharia, Yousef
Milowsky, Matthew I.
Bellmunt, Joaquim
Emamekhoo, Hamid
Davis, Nancy B.
Grivas, Petros
Gupta, Shilpa
Hoimes, Christopher J.
Campbell, Matthew T
Alva, Ajjai Shivaram
Koshkin, Vadim S
Source :: Journal of Clinical Oncology; 2/21/2023 Supplement, Vol. 41, p450-450, 1p
Publication Year :: 2023

Full Text Access

Tools